Montana

LC 1633, related to 340B, was a prefile for the 2023 state legislative session. As drafted, PBMs or health insurers may not:  

• Prohibit federally certified health entities or pharmacies from participating in the insurer’s network;  
• Reimburse a federally certified health entity or pharmacy differently than reimbursing other similarly situated pharmacies;  
• Require a claim or a drug to include a modifier to indicate that the drug is a 340B drug, unless the claim is for Medicaid payment; or 
• Create restrictions or impose additional charges on patients who choose to receive drugs from a federally certified health entity or pharmacy  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.